ATE290019T1 - Membran-sekretierte proteine - Google Patents

Membran-sekretierte proteine

Info

Publication number
ATE290019T1
ATE290019T1 AT98911164T AT98911164T ATE290019T1 AT E290019 T1 ATE290019 T1 AT E290019T1 AT 98911164 T AT98911164 T AT 98911164T AT 98911164 T AT98911164 T AT 98911164T AT E290019 T1 ATE290019 T1 AT E290019T1
Authority
AT
Austria
Prior art keywords
secreted proteins
protein
membrane
osteoblast
cells
Prior art date
Application number
AT98911164T
Other languages
English (en)
Inventor
Naoki Kimura
Tomoko Toyoshima
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE290019T1 publication Critical patent/ATE290019T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F11/00—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it
    • G01F11/10—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with measuring chambers moved during operation
    • G01F11/12—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with measuring chambers moved during operation of the valve type, i.e. the separating being effected by fluid-tight or powder-tight movements
    • G01F11/14—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with measuring chambers moved during operation of the valve type, i.e. the separating being effected by fluid-tight or powder-tight movements wherein the measuring chamber reciprocates
    • G01F11/18—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with measuring chambers moved during operation of the valve type, i.e. the separating being effected by fluid-tight or powder-tight movements wherein the measuring chamber reciprocates for fluent solid material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01F—MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME
    • G01F11/00—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it
    • G01F11/28—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with stationary measuring chambers having constant volume during measurement
    • G01F11/36—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with stationary measuring chambers having constant volume during measurement with supply or discharge valves of the rectilinearly-moved slide type
    • G01F11/40—Apparatus requiring external operation adapted at each repeated and identical operation to measure and separate a predetermined volume of fluid or fluent solid material from a supply or container, without regard to weight, and to deliver it with stationary measuring chambers having constant volume during measurement with supply or discharge valves of the rectilinearly-moved slide type for fluent solid material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Fluid Mechanics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98911164T 1997-04-01 1998-04-01 Membran-sekretierte proteine ATE290019T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9965397 1997-04-01
PCT/JP1998/001511 WO1998043998A1 (fr) 1997-04-01 1998-04-01 Nouvelle proteine secretee par une membrane

Publications (1)

Publication Number Publication Date
ATE290019T1 true ATE290019T1 (de) 2005-03-15

Family

ID=14253023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98911164T ATE290019T1 (de) 1997-04-01 1998-04-01 Membran-sekretierte proteine

Country Status (11)

Country Link
US (3) US6271366B1 (de)
EP (1) EP0976764B1 (de)
JP (1) JP4135813B2 (de)
KR (1) KR20010005892A (de)
AT (1) ATE290019T1 (de)
AU (1) AU734013B2 (de)
CA (1) CA2284734A1 (de)
DE (1) DE69829173T2 (de)
IL (1) IL132112A0 (de)
TW (1) TW562807B (de)
WO (1) WO1998043998A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
WO2001010908A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
WO2001011050A1 (en) 1999-08-04 2001-02-15 Amgen Inc. Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY
AU2001296561A1 (en) * 2000-10-04 2002-04-15 Apoxis, S.A. Tach: new tnf-receptor family nucleic acids and polypeptides
JP2004531214A (ja) * 2000-12-19 2004-10-14 スミスクライン・ビーチャム・コーポレイション 新規化合物
PT1446733E (pt) * 2001-10-13 2009-09-28 Asterion Ltd Polipéptidos contendo glicosilfosfatidilinositol
JP2006094701A (ja) * 2002-09-17 2006-04-13 Chugai Pharmaceut Co Ltd ７ｆ４遺伝子トランスジェニック動物
JP2007510434A (ja) * 2003-11-12 2007-04-26 シェーリング　コーポレイション 多重遺伝子発現のためのプラスミドシステム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510446A (ja) * 1993-03-04 1996-11-05 クリエイティブ バイオモレキュルズ，インコーポレイテッド 組換え骨形成タンパク質を生成するための方法および組成物
DE69433742T2 (de) * 1993-05-12 2005-07-07 Genetics Institute, LLC, Cambridge Bmp-10 zusammensetzungen
JPH07118296A (ja) * 1993-10-22 1995-05-09 Sumitomo Metal Ind Ltd 新規のペプチド
JPH0931098A (ja) * 1995-07-24 1997-02-04 Hoechst Japan Ltd 新規なタンパク質ｈｍｗヒトｍｐ５２

Also Published As

Publication number Publication date
US6271366B1 (en) 2001-08-07
DE69829173T2 (de) 2006-04-13
DE69829173D1 (de) 2005-04-07
WO1998043998A1 (fr) 1998-10-08
KR20010005892A (ko) 2001-01-15
US20040152879A1 (en) 2004-08-05
EP0976764B1 (de) 2005-03-02
AU6521998A (en) 1998-10-22
EP0976764A4 (de) 2001-03-21
AU734013B2 (en) 2001-05-31
EP0976764A1 (de) 2000-02-02
CA2284734A1 (en) 1998-10-08
US20020128435A1 (en) 2002-09-12
US6784284B2 (en) 2004-08-31
JP4135813B2 (ja) 2008-08-20
IL132112A0 (en) 2001-03-19
US7235640B2 (en) 2007-06-26
TW562807B (en) 2003-11-21

Similar Documents

Publication Publication Date Title
Yokoyama-Kobayashi et al. Human cDNA encoding a novel TGF-β superfamily protein highly expressed in placenta
EP1798239A3 (de) G-Protein-gekoppelte Rezeptoren und deren Verwendung
ATE271606T1 (de) Die aktivierung von rezeptoren durch gas6
DE60228477D1 (de) Verfahren zur regulierung der immunfunktion in primaten unter verwendung des foxp3-proteins
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
TR199900624T2 (xx) Proteinlerin y�ksek seviyede ekspresyonu.
ATE290019T1 (de) Membran-sekretierte proteine
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
EP0701563A4 (de) Gen transfer zur behandlung von bindegewebe eines säugetierwirtes
Garibotti et al. Three odorant-binding proteins from rabbit nasal mucosa
Engelholm et al. The urokinase plasminogen activator receptor–associated protein/Endo180 Is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis
WO1996015144A3 (en) Chromosome 21 gene marker, compositions and methods using same
PT907731E (pt) Receptores gaba[b] metabotropicos, ligandos especificos dos receptores e suas utilizacoes
Ohga et al. Activin receptors are expressed on human lung fibroblast and activin A facilitates fibroblast-mediated collagen gel contraction
PT973794E (pt) Receptores de netrina
AU5799200A (en) Lpl variant therapeutics
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
EA199900522A1 (ru) Полипептиды, кодируемые геном, подобным гену липазы человека, композиции и методы
WO2002072024A3 (en) Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
Ihara et al. Identification of interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF
Saada et al. Expression of multiple CaV1. 2 transcripts in rat tissues mediated by different promoters
AU2002320301A1 (en) Novel pgc-1 isoforms and uses therefor
Zeichner-David et al. Isolation and preliminary characterization of epithelial-specific messenger ribonucleic acids and their products during embryonic tooth development
FR2697850B1 (fr) Nouveaux polypeptides ayant une activité de récepteur opioïde, acides nucléiques codant pour ces polypeptides et utilisations.
Velan et al. Reversal of signal-mediated cellular retention by subunit assembly of human acetylcholinesterase.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties